Kotecha, D., Flather, M. D., Atar, D., Collins, P., Pepper, J., Jenkins, E., . . . Study, o. b. o. t. A. R. M. i. C. A. D. (. (2019). B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease. BMC.
Citação norma ChicagoKotecha, Dipak, Marcus D. Flather, Dan Atar, Peter Collins, John Pepper, Elizabeth Jenkins, Christopher M. Reid, David Eccleston, and on behalf of the Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study. B-type Natriuretic Peptide Trumps Other Prognostic Markers in Patients Assessed for Coronary Disease. BMC, 2019.
MLA citiranjeKotecha, Dipak, et al. B-type Natriuretic Peptide Trumps Other Prognostic Markers in Patients Assessed for Coronary Disease. BMC, 2019.
Opozorilo: Ti citati niso vedno 100% točni.